Tanaji T. Talele

5.7k total citations · 2 hit papers
98 papers, 4.5k citations indexed

About

Tanaji T. Talele is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Tanaji T. Talele has authored 98 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 42 papers in Molecular Biology and 38 papers in Infectious Diseases. Recurrent topics in Tanaji T. Talele's work include HIV/AIDS drug development and treatment (31 papers), Drug Transport and Resistance Mechanisms (26 papers) and PARP inhibition in cancer therapy (13 papers). Tanaji T. Talele is often cited by papers focused on HIV/AIDS drug development and treatment (31 papers), Drug Transport and Resistance Mechanisms (26 papers) and PARP inhibition in cancer therapy (13 papers). Tanaji T. Talele collaborates with scholars based in United States, China and Türkiye. Tanaji T. Talele's co-authors include Zhe‐Sheng Chen, Satyakam Singh, Santosh A. Khedkar, Alan C. Rigby, Neerja Kaushik‐Basu, Suresh V. Ambudkar, Maulik Patel, Liwu Fu, Bhargav A. Patel and Atish Patel and has published in prestigious journals such as Science, Nucleic Acids Research and Molecular Cell.

In The Last Decade

Tanaji T. Talele

97 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules

2016 772 citations Tanaji T. Talele profile →
Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon

2020 290 citations Tanaji T. Talele profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tanaji T. Talele United States	36	1.8k	1.8k	1.4k	589	446	98	4.5k
Hing L. Sham United States	37	2.1k 1.1×	2.0k 1.1×	558 0.4×	870 1.5×	414 0.9×	134	4.6k
Wenfang Xu China	37	3.0k 1.7×	1.7k 0.9×	1.6k 1.1×	177 0.3×	252 0.6×	266	5.2k
Yusuke Wataya Japan	40	2.4k 1.3×	1.6k 0.9×	540 0.4×	366 0.6×	199 0.4×	203	5.3k
Peter Chiba Austria	36	1.3k 0.7×	522 0.3×	1.7k 1.2×	560 1.0×	333 0.7×	127	3.3k
Tarek S. Mansour United States	43	2.2k 1.2×	2.4k 1.4×	436 0.3×	590 1.0×	164 0.4×	148	5.0k
James R. Fuchs United States	45	2.7k 1.5×	1.3k 0.7×	1.1k 0.8×	1.0k 1.7×	107 0.2×	112	5.6k
Hsing‐Pang Hsieh Taiwan	44	2.3k 1.3×	2.1k 1.2×	832 0.6×	638 1.1×	603 1.4×	152	5.3k
Nobuo Shimma Japan	26	1.0k 0.6×	807 0.5×	1.1k 0.8×	299 0.5×	192 0.4×	56	3.0k
Federico Gago Spain	42	3.3k 1.8×	1.9k 1.1×	734 0.5×	739 1.3×	546 1.2×	247	6.1k
Melinda G. Hollingshead United States	45	3.9k 2.2×	1.1k 0.6×	1.9k 1.3×	301 0.5×	353 0.8×	167	6.9k

Countries citing papers authored by Tanaji T. Talele

Since Specialization

Citations

This map shows the geographic impact of Tanaji T. Talele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanaji T. Talele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanaji T. Talele more than expected).

Fields of papers citing papers by Tanaji T. Talele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanaji T. Talele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanaji T. Talele. The network helps show where Tanaji T. Talele may publish in the future.

Co-authorship network of co-authors of Tanaji T. Talele

This figure shows the co-authorship network connecting the top 25 collaborators of Tanaji T. Talele. A scholar is included among the top collaborators of Tanaji T. Talele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanaji T. Talele. Tanaji T. Talele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Billur, Ramya, et al.. (2025). A PARP2 active site helix melts to permit DNA damage-induced enzymatic activation. Molecular Cell. 85(5). 865–876.e4. 3 indexed citations

Diolaiti, Morgan E., et al.. (2025). Discovery of a Novel [6–6–5–5–6] Pentacyclic Tetrahydrocyclopentaphthalazinone as a Promising PARP Inhibitor Scaffold. ACS Medicinal Chemistry Letters. 16(5). 776–783. 1 indexed citations

Diolaiti, Morgan E., Huadong Chen, Junhao Lu, et al.. (2025). Structure-activity relationship studies on 2-thienylidene substituted 3-oxo-2,3-dihydrobenzofuran-7-carboxamides as poly (ADP-ribose) polymerase inhibitors. Bioorganic Chemistry. 165. 108941–108941.

Velagapudi, Uday Kiran, et al.. (2024). Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaks. Biochemical Journal. 481(6). 437–460. 3 indexed citations

Ghoshal, S. P., et al.. (2023). Identification of a novel spirocyclic Nek2 inhibitor using high throughput virtual screening. Bioorganic & Medicinal Chemistry Letters. 88. 129288–129288. 3 indexed citations

Krastev, Dragomir B., Shudong Li, Yilun Sun, et al.. (2022). The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. Nature Cell Biology. 24(1). 62–73. 92 indexed citations

Zandarashvili, Levani, Marie-France Langelier, Uday Kiran Velagapudi, et al.. (2020). Structural basis for allosteric PARP-1 retention on DNA breaks. Science. 368(6486). 233 indexed citations

Zhang, Hui, De‐Shen Wang, Rishil J. Kathawala, et al.. (2014). AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance. Cancer Letters. 350(1-2). 61–68. 29 indexed citations

Huang, Xiao‐Cong, Xue Xiao, Yunkai Zhang, et al.. (2014). Lamellarin O, a Pyrrole Alkaloid from an Australian Marine Sponge, Ianthella sp., Reverses BCRP Mediated Drug Resistance in Cancer Cells. Marine Drugs. 12(7). 3818–3837. 66 indexed citations

10.

Sodani, Kamlesh, Atish Patel, Nagaraju Anreddy, et al.. (2014). Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo. Biochemical Pharmacology. 89(1). 52–61. 41 indexed citations

11.

Wang, Yi‐Jun, Rishil J. Kathawala, Yunkai Zhang, et al.. (2014). Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1. Biochemical Pharmacology. 90(4). 367–378. 48 indexed citations

12.

Golub, Andriy G., Amartya Basu, Volodymyr G. Bdzhola, et al.. (2012). Discovery of new scaffolds for rational design of HCV NS5B polymerase inhibitors. European Journal of Medicinal Chemistry. 58. 258–264. 15 indexed citations

13.

Sodani, Kamlesh, Amit K. Tiwari, Satyakam Singh, et al.. (2012). GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance. Biochemical Pharmacology. 83(12). 1613–1622. 53 indexed citations

14.

Tiwari, Amit K., Kamlesh Sodani, Chun-ling Dai, et al.. (2012). Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models. Cancer Letters. 328(2). 307–317. 101 indexed citations

15.

Xie, Jing‐Dun, Xu Zhang, Yong‐ju Liang, et al.. (2012). Neratinib Reverses ATP-Binding Cassette B1-Mediated Chemotherapeutic Drug Resistance In Vitro, In Vivo, and Ex Vivo. Molecular Pharmacology. 82(1). 47–58. 82 indexed citations

16.

Shi, Zhi, Amit K. Tiwari, Suneet Shukla, et al.. (2011). Sildenafil Reverses ABCB1- and ABCG2-Mediated Chemotherapeutic Drug Resistance. Cancer Research. 71(8). 3029–3041. 152 indexed citations

17.

Yan, Yan‐yan, Li-Sheng Zheng, Xu Zhang, et al.. (2011). Blockade of Her2/neu Binding to Hsp90 by Emodin Azide Methyl Anthraquinone Derivative Induces Proteasomal Degradation of Her2/neu. Molecular Pharmaceutics. 8(5). 1687–1697. 45 indexed citations

18.

Talele, Tanaji T., et al.. (2009). A single deletion at position 134, 135, or 136 in the beta 7–beta 8 loop of the p51 subunit of HIV‐1 RT disrupts the formation of heterodimeric enzyme. Journal of Cellular Biochemistry. 109(3). 598–605. 8 indexed citations

19.

Kaushik‐Basu, Neerja, et al.. (2008). 4-Thiazolidinones: a novel class of hepatitis C virus NS5B polymerase inhibitors. Frontiers in bioscience. Volume(13). 3857–3857. 36 indexed citations

20.

Talele, Tanaji T., et al.. (1998). Design and Synthesis of a Novel Series of Nonpeptidic HIV‐1 Protease Inhibitors*. Pharmacy and Pharmacology Communications. 4(8). 365–372. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact